Stress management is not a luxury during GLP-1 therapy
After 72 hours, the IPGTT was repeated at the beginning of the dark phase without further agonist administration
Early research suggests GLP-1 medications may also interact with stress-response systems
Eli Lilly, the maker of Zepbound and Mounjaro, had pushed back against the OFAs assertion that shortages of tirzepatide were still in place, and has also claimed that versions of the drug made by compounded pharmacies are often untested, unapproved knockoffs, according to NBC News
Light protection Keep the vial in its original box or in an opaque bag inside the refrigerator
We believe these proposals would allow CMS to calculate a payment amount in the payment amount benchmark quarter that aligns with section 1847A of the Act, rather than strictly limiting this calculation to the lower of 106 percent of ASP or 106 percent of WAC as reported for a given drug, as previously stated in the CY 2025 PFS final rule (89 FR 98244), which may not align with CMS' policy for calculating payment limits under 414.904
